Tuesday, June 16, 2026

Latest

Yamana Gold: Stifel, Canaccord Issue Flash Update Following Preliminary Results

This morning Canaccord Genuity and Stifel GMP released a flash update on Yamana Gold (TSX: YRI). This comes after Yamana released preliminary third quarter operating results. Yamana announced gold equivalent ounce production was 240,000 ounces, up 30% quarter over quarter. This number came in slightly below Stifel’s 245,000 and below Canaccord’s 218,000 estimate. Yamana’s silver production was 3,040,000 ounces, which beat Stifel’s 2,700,000 ounce estimate and Canaccord’s estimate of 2,831,000 ounces.

Canaccord’s analyst Carey MacRury commented, “the lower GEO production versus our forecasts was almost entirely due to Cerro Moro which produced 19koz gold (CG est. 31koz) and 1,679koz silver (CG est. 1,855koz),” and says that management has noted that the operation is now back to their standard output levels.

Alongside the preliminary results, Yamana Gold announced that they are increasing their 2020 production guidance. They have increased their gold equivalent ounce production to 915,000 ounces from 890,000 ounces. MacRury says that production guidance is in line with their forecasts. Comparatively, Ingrid Rico from Stifel GMP says that their estimates already included a possible upward guidance revision and “the new guidance comes broadly within our estimates for gold, but modestly higher on silver.”

Another notable thing that came out of the news release was that Yamana increased its dividend 50% to 10.4 cents a share from 7 cents a share prior. This makes Yanama the second-highest dividend yield company among the senior producers. MacRury says, “We estimate a dividend payout ratio of 30% of sustaining FCF at $1,350/oz, a level that we consider sustainable.”

MacRury says that, “Q3/20 ending cash balance implies improved FCF amid record gold prices.” MacRury is currently forecasting free-cash-flow for the fourth quarter to be $133 million, a record for the company.

Rico says, “We expect the next key catalyst for the company this quarter to be the Malartic UG exploration update (mainly East Gouldie). Malartic UG will likely be getting a bigger spotlight and the upcoming exploration update should be important ahead of an initial PEA planned for 1H 2021.”

Currently, Canaccord Genuity has an C$11 price target and a Buy rating on the company. At the same time, Stifel has a C$9.75 price target and a Buy rating as well.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Why Silver’s Next Move May Be Built on a Much Stronger Base | Mani Alkhafaji – First Majestic Silver

Guanajuato Silver Q1 Earnings: They Finally Post Positive Net Income

We’re in a New Era of Gold Price Discovery | Ryan King – Equinox Gold

Recommended

Antimony Resources Drills 5.45% Antimony Over 10.3 Metres At Bald Hill

PTX Metals Hits 92% Copper Recovery in Debut W2 Testwork

Related News

Exploits Obtains Drill Permits For Little Joanna Veins Prospect

Exploits Discovery (CSE: NFLD) has received additional permits for its planned 2021 drill programs. The...

Tuesday, April 13, 2021, 09:01:35 AM

Activision: “A More Obvious Choice To Develop A Viable NFT Strategy”

Activision Blizzard (NASDAQ: ATVI) is has seen a solid climb off the monthly lows after...

Monday, May 17, 2021, 02:29:00 PM

Magna: Analysts Upgrade En Masse Following Earnings Beat

On February 19th, Magna International (TSX: MG) announced its fourth quarter and full year financials...

Saturday, February 27, 2021, 01:55:00 PM

Raymond James Reiterates $6 Price Target On Organigram Holdings

On April 6th, Organigram Holdings (TSX: OGI) (NASDAQ: OGI) announced that they acquired cannabis 2.0...

Thursday, April 8, 2021, 10:37:00 AM

Antibe: Canaccord Lowers Price Target After Co-Leading $40.4 Million Financing

Wednesday, Antibe Therapeutics (TSX: ATE) announced that they closed their bought deal financing. The bought...

Friday, February 26, 2021, 11:55:00 AM